Search Beyond News…

ASML's zero sales in Europe underscore the shortfall of the EU Chips Act and signal weak regional investment in semiconductor manufacturing

Executive summary: ASML recorded zero sales of its semiconductor manufacturing equipment in Europe. This underscores gaps in the EU Chips Act and indicates insufficient investment in European semiconductor fabrication capacity.

Who is involved: ASML (Netherlands), European Commission, European chip manufacturers.

Likely next: The European Commission may revise the Chips Act or introduce new incentives to stimulate equipment orders and capacity expansion.

ASML reported that it sold none of its advanced semiconductor manufacturing machines in Europe, according to Le Monde. This highlights shortcomings in the European Union's initial Chips Act, which aimed to boost regional chip production. The lack of orders suggests that European chipmakers are not expanding capacity, potentially affecting the region's goals for semiconductor self-sufficiency. Analysts note that the situation may prompt the Commission to revise its chips strategy or increase subsidies.

What's next — scenarios

Base: Chips Act revised with modest incentives (50%)

ASML sees a gradual increase in European equipment orders as subsidies take effect.

Upside: Strong EU stimulus drives rapid ASML sales recovery (30%)

European orders rebound sharply, boosting ASML's revenue and reinforcing regional chip sovereignty.

Downside: Investment shortfall persists, ASML shifts focus to Asia (20%)

European orders remain flat, ASML prioritizes Asian markets and Europe's chip self-sufficiency goal slips further.

What to watch

Timeline

Analysis — what this means

Sectors affected

Regulatory implications

Key entities

Sources

Related cases

Browse the full archive →